In BRCA1-associated cancers, the homologous recombination defect renders tumours highly sensitive to chemotherapy that causes double strand breaks (DSBs) in the DNA replication phase of the cell cycle, when homologous recombination is the dominant DSB repair mechanism. Here, BRCA1 is linked to neoplasm.